Reducing mortality in severe sepsis and septic shock
- PMID: 21506056
- DOI: 10.1055/s-0031-1275532
Reducing mortality in severe sepsis and septic shock
Abstract
Severe sepsis is one of the most common reasons for critically ill patients to be admitted to an intensive care unit (ICU) and has very high associated morbidity and mortality. The Surviving Sepsis Campaign was initiated with the hope that mortality might be reduced by standardizing care informed by data from an increasing number of clinical trials. Important methods for reducing mortality identified by recent studies include aggressive fluid resuscitation, early goal-directed therapy (EGDT), early administration of antibiotics, and the administration of activated protein C to eligible patients.
© Thieme Medical Publishers.
Similar articles
-
Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.Pediatr Emerg Care. 2008 Dec;24(12):810-5. doi: 10.1097/PEC.0b013e31818e9f3a. Pediatr Emerg Care. 2008. PMID: 19050666
-
Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.Acad Emerg Med. 2006 Jan;13(1):109-13. doi: 10.1197/j.aem.2005.08.005. Epub 2005 Dec 19. Acad Emerg Med. 2006. PMID: 16365336
-
Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.Dis Mon. 2004 Apr;50(4):168-213. doi: 10.1016/j.disamonth.2003.12.003. Dis Mon. 2004. PMID: 15133467 Review.
-
The current management of septic shock.Minerva Med. 2008 Oct;99(5):431-58. Minerva Med. 2008. PMID: 18971911 Review.
-
Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations.Int J Antimicrob Agents. 2006 Feb;27(2):97-101. doi: 10.1016/j.ijantimicag.2005.11.003. Epub 2006 Jan 18. Int J Antimicrob Agents. 2006. PMID: 16417989 Review.
Cited by
-
Analysis of prognostic factors in patients with emergency sepsis.World J Clin Cases. 2023 Sep 6;11(25):5903-5909. doi: 10.12998/wjcc.v11.i25.5903. World J Clin Cases. 2023. PMID: 37727482 Free PMC article.
-
Sepsis-associated acute kidney injury - is it possible to move the needle against this syndrome?J Pediatr (Rio J). 2017 Jan-Feb;93(1):1-3. doi: 10.1016/j.jped.2016.09.001. Epub 2016 Oct 13. J Pediatr (Rio J). 2017. PMID: 27746155 Free PMC article. No abstract available.
-
Eosinopenia as a Marker of Outcome in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.Maedica (Bucur). 2015 Mar;10(1):10-3. Maedica (Bucur). 2015. PMID: 26225143 Free PMC article.
-
Combining Serum Procalcitonin Level, Thromboelastography, and Platelet Count to Predict Short-term Development of Septic Shock in Intensive Care Unit.Curr Med Sci. 2023 Feb;43(1):86-92. doi: 10.1007/s11596-022-2689-y. Epub 2023 Feb 8. Curr Med Sci. 2023. PMID: 36752938
-
Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.Infect Immun. 2013 Jun;81(6):2178-89. doi: 10.1128/IAI.00265-13. Epub 2013 Apr 1. Infect Immun. 2013. PMID: 23545303 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical